Skip to main content
. 2021 Nov 13;13(11):4063. doi: 10.3390/nu13114063

Table 2.

Characteristics of 26,821 participants according to MAFLD status.

MAFLD Non-MAFLD
No. of participants (%) 10,508 (39.2) 16,313 (60.8)
Age at baseline (years) 60.4 ± 6.7 61.0 ± 6.9
Male (%) 3945 (37.5) 7049 (43.2)
High school and above (%) 1060 (10.1) 1595 (9.8)
Married (%) 9850 (93.7) 15,109 (92.6)
Current smoker (%) 1891 (18.0) 3543 (21.7)
Current drinker (%) 1369 (13.0) 2215 (13.6)
Moderate and vigorous physical activity (%) 2610 (24.8) 3711 (22.8)
Family history of diabetes (%) 1355 (12.9) 1571 (9.6)
Family history of hypertension (%) 4622 (44.0) 6140 (37.6)
BMI (kg/m2) 26.7 ± 2.9 23.3 ± 2.8
SBP (mmHg) 140.3 ± 18.5 134.1 ± 18.9
DBP (mmHg) 82.7 ± 9.9 79.6 ± 10.1
FBG (mmol/L) 5.43 ± 1.70 5.00 ± 1.27
ALT (IU/L) 20 (16–28) 16 (13–21)
TC (mmol/L) 5.10 ± 0.99 4.96 ± 0.91
TG (mmol/L) 1.73 (1.27–2.42) 1.22 (0.92–1.64)
HDL-C (mmol/L) 1.30 ± 0.31 1.48 ± 0.36
LDL-C (mmol/L) 2.86 ± 0.89 2.83 ± 0.82
Diabetes (%) 2732 (26.0) 1787 (11.0)
Hypertension (%) 7503 (71.4) 8555 (52.4)
Dyslipidemia (%) 5360 (51.0) 4348 (26.7)

Data are presented as mean ± SD or median (IQR) or number (percentage). ALT, alanine aminotransferase; BMI, body mass index; DBP, diastolic blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MAFLD, metabolic associated fatty liver disease; SBP, systolic blood pressure; TC, total cholesterol; TG, triglycerides. All p values are <0.05 for comparison across groups, with the exception of education level and drinking status.